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High-density lipoprotein (HDL) mediated reverse cholesterol transport (RCT) is regarded to be crucial
for prevention of foam cell formation and atherosclerosis. ABC-transporter A1 (ABCA1) and scavenger
receptor BI (SR-BI) are involved in the biogenesis of HDL and the selective delivery of HDL cholesterol
to the liver, respectively. In the present study, we phenotypically characterized mice lacking these two
proteins essential forHDLmetabolism.ABCA1× SR-BIdoubleknockout (dKO)mice showedseverehypoc-
holesterolemia mainly due to HDL loss, despite a 90% reduction of HDL cholesterol uptake by liver. VLDL
production was increased in dKO mice. However, non-HDL cholesterol levels were reduced, probably
due to enhanced clearance via LRP1. Hepatobiliary cholesterol transport and fecal sterol excretion wereeverse cholesterol transport not impaired in dKO mice. In contrast, the macrophage RCT in dKO mice was markedly impaired as com-
pared to WT mice, associated with the accumulation of macrophage foam cells in the lung and Peyer’s
patches. Strikingly, no atherosclerotic lesion formation was observed in dKO mice. In conclusion, both
ABCA1 and SR-BI are essential for maintaining a properly functioning HDL-mediated macrophage RCT,
while the potential anti-atherosclerotic functions of ABCA1 and SR-BI are not evident in dKO mice due
to the absence of pro-atherogenic lipoproteins.. Introduction
Plasma HDL cholesterol levels are inversely correlated with the
isk of atherosclerotic vascular disease [1]. HDL-mediated reverse
holesterol transport (RCT), a process in which excess periph-
ral cholesterol is removed and delivered to the liver for biliary
ecretion, has been regarded crucial for prevention of foam cell for-
ation and atherosclerosis [2]. Two important genes recognized in
CT are the ATP-binding cassette transporter A1 (ABCA1) and the
cavenger receptor class B type I (SR-BI) [2]. ABCA1 promotes the
fﬂux of cholesterol and phospholipid to lipid-poor apolipoprotein
I (ApoAI), leading to HDL particle maturation, the ﬁrst step in RCT
2]. In contrast, SR-BI facilitates the bi-directional ﬂux of choles-
∗ Corresponding author. Tel.: +31 071 527 6213; fax: +31 071 527 6032.
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terol between cells andmatureHDLdownaconcentrationgradient.
Importantly, SR-BI is essential for the selectiveuptakeof cholesteryl
esters (CEs) from HDL by the liver for biliary secretion, the last step
in RCT [2].
Recent genome-wide association studies (GWAS) have identi-
ﬁed ABCA1 as a major gene inﬂuencing HDL levels in humans [3].
Targeted deletion of ABCA1 in the liver [4] and intestine [5] of mice
has revealed the crucial roles of hepatic and intestinal ABCA1 for
HDL biogenesis. In agreement, induction of hepatic and intesti-
nal ABCA1 expression increases plasma HDL cholesterol (HDL-C)
levels [4,6]. In contrast, macrophage ABCA1 minimally contributes
to plasma HDL cholesterol [7]. Patients with functional mutations
in ABCA1 have Tangier disease (TD), characterized by a marked
reduction in plasma HDL-C and increased macrophage foam cell
Open access under the Elsevier OA license.formation in several tissues [8]. Likewise, ABCA1 knockout (KO)
micedisplay the similar pathophysiologic phenotypeas TDpatients
[9]. Cells from patients with TD and ABCA1 KO mice are defective
in the efﬂux of cholesterol and phospholipid to apoAI and partially
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Fig. 1. Hypocholesterolemia and HDL loss in ABCA1/SR-BI double knockout mice. Total plasma cholesterol levels (A), lipoprotein distribution of total cholesterol (B), HDL
cholesterol levels (C), and non-HDL cholesterol levels (D) of WT, ABCA1 KO, SR-BI KO and ABCA1/SR-BI double KO mice (mixed male and female) at the age of 12–16 weeks old
on chow. Bar graphs represent the mean± SEM (n=8). Two hundred microliters of pooled mouse plasma from the different genotypes were fractioned by FPLC. Statistically
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o HDL [8]. Also, macrophage RCT is impaired in ABCA1 KO mice,
ainly due to HDL deﬁciency [10,11].
In several population studies, a clear association between
utations in the coding and promoter regions of human SR-
I and increased plasma HDL-C has been shown [12,13]. Recent
WAS also demonstrated that single nucleotide polymorphism
SNPs) in and near SR-BI are signiﬁcantly associated with plasma
evels of HDL-C in humans [14]. However, only very recently
onclusive evidence was provided on the importance of SR-BI
or controlling HDL-C levels in humans. Vergeer et al. identiﬁed
family in which heterozygous carriers of a unique mutation
P297S) in the extracellular domain of SR-BI showed 37% ele-
ated HDL cholesterol levels [15]. Importantly, hepatocytes that
xpressed the P297S mutant SR-BI displayed a reduced capac-
ty to take up CEs from HDL, thereby leading to the elevation
n plasma HDL-C [15]. Also, SR-BI KO mice display increased
DL-C, due to impaired delivery of HDL-CEs to liver [16]. Inter-
stingly, despite the high levels of HDL-C, SR-BI deﬁcient mice
ave impaired macrophage RCT [17]. Conversely, overexpres-
ion of hepatic SR-BI decreases HDL-C and promotes macrophage
CT [17].
Given that ABCA1 and SR-BI are involved in the different steps of
CT, it is conceivable thatABCA1andSR-BImight act synergistically
n the process of RCT. To study the RCT process under conditions in
hich both of these key mediators are absent, ABCA1/SR-BI double
nockout (dKO) mice were generated. In this study, we describe
he characterization of ABCA1/SR-BI dKO mice with respect to
lasma lipids, HDL metabolism, blood cell counts, bile secretion,
acrophage RCT, tissue cholesterol homeostasis, and atheroscle-
osis susceptibility.2. Materials and methods
For detailed methodology, please see the data supple-
ment, available online at http://www.sciencedirect.com. Brieﬂy,
ABCA1/SR-BI dKO mice were generated by intercrossing double
heterozygous offsprings obtained from crossbreeding of ABCA1 KO
mice with SR-BI KO mice. Plasma cholesterol levels, the lipopro-
tein distribution, blood cell counts, and hepatic expression of
lipoprotein receptors, including SR-BI, LDL receptor (LDLr), and
LDLr related protein 1 (LRP1) were determined. Moreover, VLDL
production, serumdecay and liver uptakeof [3H]-cholesteryl ether-
labeled HDL, hepatobiliary and fecal cholesterol secretion, and
macrophage RCT were analyzed. In addition, tissue macrophage
cholesterol homeostasis and atherosclerosis susceptibility were
examined by Oil-red-O staining and immunohistochemical stain-
ing against Moma-2.
3. Results
3.1. Hypocholesterolemia and HDL loss in ABCA1/SR-BI dKO mice
To analyze the potential synergistic role of ABCA1 and SR-BI
in the RCT process, we generated ABCA1/SR-BI dKO mice. The
absence of ABCA1 and SR-BI in the dKO mice was veriﬁed at
DNA level by performing PCR on genomic DNA (Supplementary
Fig. 1). From the crosses of ABCA1/SR-BI double heterozygous
mice, 7.2%, 6.5%, and 6.2% of the offspring were ABCA1 KO, SR-
BI KO, and dKO mice, which are close to the expected Mendelian
inheritance rate of 6.25%. Homozygous dKO males are fertile
while dKO females, similar to SR-BI KO females [18,19], are
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Fig. 2. Reduced serum decay and liver uptake of [3H]CEt-HDL in ABCA1/SR-BI double knockout mice. Serum decay and liver uptake was determined in 12–16 week old female
animals on chow diet. (A) The clearance of [3H]CEt-HDL from the circulation in WT (×), ABCA1 KO (), SR-BI KO () and ABCA1/SR-BI double KO (©) mice at 0, 1, 2, 4, and
24h after intravenous injection of 200g [3H]CEt-HDL. (B) The amount of [3H]CEt-HDL in the circulation and the liver at 4h after injection. (C) The amount of [3H]CEt-HDL in
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##p<0.001 vs ABCA1 KO mice; $$$p<0.001 vs SR-BI KO mice.
nfertile,which could be reversed by administering the cholesterol-
owering drug probucol. However, as described for ABCA1 KO
ice [20], also under these conditions a lower frequency of preg-
ancy and extensive neonatal death of pups born from dKO
others was observed. No signiﬁcant differences in body weight
etween wild-type (WT), ABCA1 KO, SR-BI KO, and dKO mice
ere observed at the age of 12 weeks (22.7±0.9 g, 20.3±0.3 g,
2.0±0.6 g, 21.3±0.3 g, respectively). Furthermore, dKOmiceborn
rom ABCA1× SR-BI double heterozygous breedings did not appear
o have a reduced life expectancy as they can reach ages of >
year.
In line with previous studies [8,9,18,19], SR-BI KO mice showed
ncreasedplasma free (5.5-fold,p<0.001) and total cholesterol (2.0-
old, p<0.001) levels as compared to WT animals and accumulated
bnormally large HDL particles. ABCA1 KO mice on the con-
rary were severely hypocholesterolemic and had a near complete
bsence of HDL (Fig. 1A–C and Supplementary Table 4). Mice with
combined deﬁciency of ABCA1 and SR-BI resembled single ABCA1
O mice with a dramatic >80% and >99% decrease in the plasma TC
nd HDL-C levels, respectively (Fig. 1A–C). Of note, ABCA1 deﬁ-
iency dramatically reduced the plasma free cholesterol levels
22-fold, p<0.001) in the SR-BI KO background (Supplementary
able 4). SR-BI deﬁciency also led to an increase in plasma lev-
ls of phospholipids (1.2-fold, p<0.001) and triglycerides (1.2-fold,
< 0.05). In contrast, both ABCA1 KO and dKO mice showed com-
arably reduced plasma levels of phosholipids (3.0-fold, p<0.001(n=3/group). Statistically signiﬁcant difference **p<0.01, ***p<0.001 vs WT mice;
vsWT) and triglycerides (1.7-fold, p<0.001 vsWT) (Supplementary
Table 4).
Serum decay and hepatic uptake of HDL-CE in dKO mice
were studied next. Upon injection of [3H]CEt-HDL into WT mice,
60.3±1.3% of the injected label was removed from the blood dur-
ing the ﬁrst 4h (Fig. 2A and B). Consistent with previous ﬁndings
[21], serum clearance was severely delayed upon deletion of SR-
BI. At 4h after injection only 35.4±1.9% (p<0.001) was removed
from the circulation in SR-BI KO mice. Notably, in ABCA1 KO mice,
87.6±1.4% (p<0.001) of the injected label was removed from the
circulation at 4h after injection. Combined disruption of ABCA1
and SR-BI led to a signiﬁcantly delayed serum clearance of [3H]CEt-
HDL (48.6±1.1% removed at 4h, p<0.001 vs WT mice; p<0.001 vs
ABCA1 KO mice). Importantly, these ﬁndings in the dKO mice for
the ﬁrst time show that SR-BI deﬁciency dramatically decreases
HDL-CEt clearance in the absence of a circulation pool of HDL. At
this time point, in WT mice, 26.5±1.5% of the injected dose (ID)
was recovered in the liver while ABCA1 KO mice showed a 1.7-fold
(46.0±3.1%, p<0.001) increase in uptake by the liver (Fig. 2B). In
contrast, only 3.5±0.6% (p<0.001 vs WT) and 3.2±0.3% (p<0.001
vsABCA1KO) of the ID accumulated in the liver of SR-BI KOanddKO
mice, indicating that SR-BI is responsible for the majority (around
80–90%) of the removal of CEt from HDL in the circulation by liver.
Moreover, the distribution of radioactivity over extrahepatic tis-
sues was also analyzed at 4h after injection (Supplementary Table
3). It was found that the majority of the extrahepatic label was
Y. Zhao et al. / Atherosclerosi
Fig. 3. Increased VLDL production in ABCA1/SR-BI double knockoutmice. VLDL pro-
duction rate was determined in 12–16 week old female animals on chow diet.
VLDL production was determined by calculating the accumulation rate (g/h/kg
body weight) of triglycerides in the plasma after blocking VLDL clearance by Triton
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ABCA1 and SR-BI on macrophage-speciﬁc RCT. First, bone marrow-R-1339. Data are expressed as mean± SEM (n=5/group). Statistically signiﬁcant
ifference **p<0.01, ***p<0.001 vs WT mice; $$$p<0.001 vs SR-BI KO mice.
resent in bone (6–9%), skin (4–9%), and the muscle (1–3%). The
otal recovery of label was between 79 and 82%. In line with pre-
ious study [21], SR-BI deﬁciency also led to an ∼88% (p<0.001 vs
T) reduction of [3H]CEt uptake by adrenal. Similarly, the adrenal
ptake of [3H]CEt in dKOmicewas also dramatically decreased 85%
p<0.001) and 97% (p<0.001) as compared to WT and ABCA1 KO
ice, respectively (Supplementary Table 3). Interestingly, ABCA1
eﬁciency led to 6-fold (p<0.001 vs WT) more adrenal uptake of
3H]CEt. Also a 3-fold (p<0.01) increase in skin uptake of [3H]CEt
as observed in ABCA1 KO mice as compared to WT mice. How-
ver, the absoluteuptakebyadrenal and skin inABCA1KOmicewas
nly 3.5% and 2.6% of ID. Thus, increased clearance of [3H]CEt-HDL
rom the circulation in ABCA1 KO mice as compared to WT ani-
als was mainly due to enhanced uptake by the liver. After 24h,
bove 90% of injected [3H]CEt-HDL was removed from the circula-
ion inWT,ABCA1KO, anddKOmicewhereas30.0±0.8% (p<0.001)
f the injected label remained in the circulation of SR-BI KO mice
Fig. 2A and C). At this time point, 46.0±2.3% and 50.1±3.4% of ID
ere recovered in the liver of WT and ABCA1 KO mice. In contrast,
nly 10.2±0.3% (p<0.001 vsWT)and5.9±0.2% (p<0.001 vsABCA1
O) of the ID had accumulated in livers of SR-BI KO and dKO mice,
espectively (Fig. 2C).
In linewithpreviousﬁndings [22], deletionof SR-BI also resulted
n a 1.3-fold (p<0.05) increase in non-HDL-C levels (Fig. 1D). Inter-
stingly, non-HDL-C levels were reduced 4.2-fold (p<0.001) and
.1-fold (p<0.001) in ABCA1 KO and dKO animals, respectively as
ompared to WT mice (Fig. 1D). However, ABCA1 deﬁciency did
ead to a 1.5-fold (p<0.001) and 1.8-fold (p<0.01) higher VLDL
roduction rate against both the WT and SR-BI KO background,
espectively (Fig. 3A). The observed reduction in non-HDL-C in
BCA1 KO and dKO mice was thus not the result of an impaired
epatic VLDL secretion. Next, we analyzed the hepatic expression
f ABCA1, SR-BI, LDLr, and LRP1 at both the mRNA and the pro-
ein level. As anticipated, deletion of ABCA1 and/or SR-BI resulted
n undetectable mRNA and protein expression of the respective
roteins in the liver (Fig. 4). ABCA1 deﬁciency did not affect the
xpression of hepatic SR-BI. Thus, the observed increased accumu-
ation of [3H]CEt-HDL in the liver of ABCA1 KO mice might be due
o the lack of an endogenous HDL pool, which could compete with
3H]CEt-HDL inbindingwithhepatic SR-BI. ThemRNA levels of LDLr
nd LRP1 were increased 2.5-fold (p<0.01) and 2.0-fold (p<0.01),
espectively in the liver of dKO mice as compared to WT and single
Os (Fig. 4A). However, only the protein levels of hepatic LRP1weres 218 (2011) 314–322 317
signiﬁcantly upregulated 1.7-fold (p<0.05) in the dKOs (Fig. 4B).
Strikingly, the protein levels of the LDLr in livers of the dKO mice
were dramatically reduced (4-fold, p<0.05) (Fig. 4B). Since dKO
mice showed 3-fold (p<0.01) higher hepatic expression of PCSK9
protein as compared to WT mice and single KOs (Supplementary
Fig. 2A), the reduced LDLr protein levels in the liver might be due to
enhanced degradation of the LDLr via PCSK9 [23] (Supplementary
Fig. 2A). In addition, the expression of P2Y13, an important player
in HDL metabolism [24], was also analyzed by Western blot. As
shown in Supplementary Fig. 2B, single ABCA1 and SR-BI deﬁciency
did not affect the expression of P2Y13 in the liver. In contrast, dKO
mice showed slightly increased hepatic levels of P2Y13 (1.5-fold,
p<0.05 vs WT mice and single KOs).
3.2. Normalized red blood cell and reticulocyte counts in
ABCA1/SR-BI dKO mice
Circulating white and red blood cells were next analyzed. No
signiﬁcant differences in white blood cells, including lymphocytes,
monocytes, and granulocytes were observed among the different
strains of animals (Supplementary Table 5). In line with previous
study [25,26], SR-BI KO mice showed a slightly reduced red blood
cell (RBC) count (10.0±0.1×109/mL vs 11.1±0.2×109/mL in WT
mice, p<0.01) with an increased reticulocyte count (215±15‰ vs
34±1‰ inWTmice,p<0.0001) (SupplementaryTable5).Nosignif-
icant differences in the RBC (11.5±0.2×109/mL) and reticulocyte
(36±2‰) count were found in ABCA1 KO mice as compared to WT
mice. Notably, ABCA1 deﬁciency normalized the RBC and reticulo-
cyte counts in SR-BI KO mice (dKO mice: RBC, 10.8±0.3×109/mL,
p<0.05; reticulocyte, 38±5‰, p<0.001 vs SR-BI KO). This is most
likely the consequence of the large reduction in FC levels in the dKO
mice [25,26].
3.3. Unaltered hepatic lipid content and biliary and fecal sterol
secretion in ABCA1/SR-BI dKO mice
Hepatic total cholesterol, phospholipids, and triglycerides lev-
els were not changed in dKO mice as compared to WT and single
KOs (Supplementary Table 6). In line with one previous study [27],
ABCA1 deﬁciency did not inﬂuence biliary cholesterol secretion.
Also, the biliary secretion rate of cholesterol was not impaired in
dKO mice, although a slight but not signiﬁcant decrease in bil-
iary cholesterol secretion was observed in SR-BI KO mice. The
expression of ABCG5 and ABCG8, important cholesterol trans-
porters on hepatic canalicular membrane [28], was unaffected in
SR-BI KO and dKO mice (Supplementary Fig. 2C and D). More-
over, biliary secretion of phospholipid and bile salts were lower
in dKO mice, but the differences were not statistically signiﬁcant,
which might be due to the high variation among the animals
(Supplementary Table 6). Furthermore, dKO mice produced sim-
ilar amount of feces (1.26±0.35g/day) as compared to WT mice
(1.13±0.08g/day). Lipid analysis of fecal samples showed that
combined deﬁciency of ABCA1 and SR-BI did not affect fecal choles-
terol (2.34±0.04 vs 2.43±0.09mmol/kg) and bile salt content
(12.75±2.28 vs 10.30±0.65mmol/kg) as compared to WT mice.
Thus, despite the absence of HDL, ABCA1 deﬁciency did not alter
the hepatic lipid content and biliary and fecal sterol secretion in
either the WT or the SR-BI KO background.
3.4. Impaired macrophage RCT in ABCA1/SR-BI dKO mice
Next, we investigated the effect of combined deﬁciency ofderived macrophages from WT, ABCA1 KO, SR-BI KO, and dKO mice
were loaded with [3H]-cholesterol and acetylated LDL (acLDL). The
lipid-laden macrophages were subsequently injected intraperi-
318 Y. Zhao et al. / Atherosclerosis 218 (2011) 314–322
Fig. 4. Expression levels of ABCA1, SR-BI, LDLr, and LRP1 in livers of ABCA1/SR-BI dKO mice. Livers were harvested from 16-week old chow-fed WT, ABCA1 KO, SR-BI KO,
and dKO mice and total RNA and protein were isolated for real-time PCR analysis (A, n=6) and Western blotting analysis (B, n=3), respectively as described in Section 2. The
expression levels in livers of WT animals were normalized to 1. Data are expressed as mean± SEM. Statistically signiﬁcant difference *p<0.05, **p<0.01, ***p<0.001 vs WT
mice; #p<0.05, ##p<0.01, ###p<0.001 vs ABCA1 KO mice; $p<0.05, $$p<0.01, $$$p<0.001 vs SR-BI KO mice.
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±ig. 5. Impaired macrophage-speciﬁc reverse cholesterol transport in ABCA1/SR-BI doubl
ith [3H]-cholesterol and acetylated LDL (5Ci/mL, 100g/mL) for 48h. After equilibra
nto male WT, ABCA1 KO, SR-BI KO and ABCA1/SR-BI double knockout mice at the age of
fter injection and the tracer levels in various samples were measured. Data are expresse
SEM (n=6). *p<0.05, **p<0.01, ***p<0.001 vs WT mice; ###p<0.001 vs SR-BI KO mice.e knockout mice. Peritoneal macrophages from WT mice were prepared and labeled
tion, [3H]-cholesterol labeled macrophage foam cells were harvested and injected
12–16 weeks old on chow. Blood (A), liver (B), and feces (C) were collected at 24h
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oneally into WT mice, and the transport of labeled cholesterol
o blood, liver, and feces was measured at 24h after the injec-
ion. Consistent with previous ﬁndings [11], ABCA1 deﬁciency on
acrophagesdid result in a∼20% reduction (p<0.05) in theamount
f tracer excreted into feces. However, given that the expression
f macrophage SR-BI was undetectable after cholesterol loading,
e could not pick up the effect of macrophage SR-BI deﬁciency
n RCT in this experimental setting (Supplementary Fig. 3). Thus,
e next quantiﬁed the release of [3H]-cholesterol from acLDL-
oaded WT macrophages to the plasma and their transport to the
iver and ultimately the feces in WT, ABCA1 KO, SR-BI KO and
KO mice. In line with previous ﬁndings [10,11,17], at 24h after
njection, the absence of HDL due to ABCA1 deﬁciency resulted
n a signiﬁcant reduction of 3H-cholesterol in plasma (13.5-fold,
< 0.001), liver (1.5-fold, p<0.05), and feces (1.3-fold, p<0.05) (Fig.
). SR-BI KO mice with impaired hepatic uptake of HDL-CE had
igniﬁcantly increased 3H-cholesterol (1.7-fold, p<0.001) in the
lasma but reduced 3H-cholesterol in the liver (1.4-fold, p<0.05)
nd feces (1.3-fold, p<0.05) (Fig. 5). Combined deﬁciency of ABCA1
nd SR-BI also led to a signiﬁcant reduction of 3H-cholesterol in
he plasma (13.3-fold, p<0.001), liver (1.7-fold, p<0.05), and feces
1.4-fold, p<0.05). However, no added effect of ABCA1 and SR-BI
n the reverse transport of cholesterol from WT macrophages was
bserved.
.5. Tissue cholesterol homeostasis in ABCA1/SR-BI dKO mice
To assess the morphological changes associated with combined
BCA1 and SR-BI deﬁciency, a necropsy of the mice at the age of
6 weeks old on chow diet was performed. No signiﬁcant differ-
nces were observed in liver weight between WT, ABCA1 KO, SR-BI
O, anddKOmice (50.0±1.8mg/g, 55.3±2.1mg/g, 56.0±3.0mg/g,
2.5±3.3mg/g body weight, respectively). In line with previous
ndings [8,25,26], ABCA1 KO mice and SR-BI KO mice showed a
.3-fold (4.4±0.2mg/g, p<0.05) and a 3.3-fold (11.0±0.5mg/g,
< 0.001) increase in spleen weight, respectively as compared to
T mice (3.3±0.2mg/g body weight). Interestingly, the spleen
eight of dKO mice was increased 1.9-fold to 6.3±0.7mg/g body
eight (p<0.001 vs WT), which was signiﬁcantly lower than the
pleen weight of SR-BI KO mice (1.7-fold, p<0.001) and higher
han the spleen weight of ABCA1 KO mice (1.4-fold, p<0.01). The
plenomegaly observed in SR-BI KO mice was associated with
nhanced erythropoiesis in the spleen and the accumulation of
eticulocytes in the blood, due to the abnormally high plasma FC
evels [25,26].ABCA1deﬁciencydid lowerplasmaFC levels andnor-
alized the counts of reticulocytes in the circulation of SR-BI KO
ice (Supplementary Tables 4 and 5). The splenomegaly observed
n the dKO mice thus cannot be the result of enhanced erythro-
oiesis.
To further determine the effect of combineddeﬁciency of ABCA1
nd SR-BI on tissue cholesterol homeostasis, cryostat sections of
iver, spleen, lung, thymus, and Peyer’s patches in mice at the age
f 16 weeks old on chow were stained for neutral lipids with Oil-
ed-O. Interestingly, no visible lipid accumulation was found in
iver, spleen, and thymus in WT, single ABCA1 KO, single SR-BI KO,
nd dKO mice at the age of 16 weeks (data not shown). Thus, the
plenomegaly observed in single and double KOs was also not due
o lipid accumulation. Consistent with previous ﬁndings [9], neu-
ral lipid accumulationwasobserved in the lungof the singleABCA1
Os. Also, Peyer’s patches of ABCA1 KOs showed red staining with
il-red-O, consistent with lipid accumulation. Strikingly, dKO mice
isplayed more extreme macrophage foam cell formation in the
ung and Peyer’s patches as evidenced by colocalization of Oil-red-
with Moma-2 macrophage staining (Fig. 6A). Lipid quantiﬁcation
ndicated that accumulated neutral lipid in the lung is cholesterol
ster (dKO: 204.2±31.04g/mg protein vs WT: 1.8±1.2g/mgs 218 (2011) 314–322 319
protein, p<0.001). Furthermore, atherosclerosis was analyzed at
the aortic root of seperatemice at the age of 1 year old on chowdiet.
As shown in Fig. 6B, no atherosclerotic lesions were evident in the
WT, ABCA1 KO, and SR-BI KO mice. Despite enhanced macrophage
foam cell formation in the lung and Peyer’s patches, also dKO mice
did not develop any atherosclerotic lesions, even at the age of 1
year. This is most likely due to the fact that the dKO mice lack the
high plasma levels of atherogenic lipoproteins needed to trigger
arterial wall accumulation of macrophages.
4. Discussion
In the current study, we for the ﬁrst time phenotypically char-
acterized ABCA1/SR-BI dKOmice, and studied the interrelationship
between ABCA1 and SR-BI in macrophage RCT using these unique
dKO mice lacking both transporters essential for HDL metabolism.
ABCA1/SR-BI dKO mice resembled single ABCA1 KO mice in HDL
loss and hypocholesterolemia. Although the transport of choles-
terol from WT macrophages to feces was impaired in dKO mice,
combined deﬁciency of ABCA1 and SR-BI did not result in an addi-
tive effect as compared to the rate of cholesterol transport to feces
in single ABCA1 KO and SR-BI KO mice. Interestingly, enhanced
macrophage foam cell formation was evident in the lung and
Peyer’s patches of dKO mice, clearly illustrating the importance of
both ABCA1 and SR-BI for macrophage cholesterol homeostasis in
these organs. However, no atherosclerotic lesion development was
observed in these dKOs, even at the age of 1 year, probably due to
the low levels of non-HDL-C.
SR-BImediatedhepatic uptake ofHDL cholesterol is nearly com-
pletely blocked in SR-BI KO and dKO mice, similar as in SR-BI KO
mice. However, with respect to the lipid levels in the plasma and
the lipoprotein distribution of cholesterol, our dKO mice resem-
bled single ABCA1 KO mice. The HDL loss in the dKO mice is thus
due to impaired HDL production, similarly as previously described
for single ABCA1 KO mice [29]. Although ABCA1 deﬁciency did
not affect the hepatic expression of SR-BI, ABCA1 KO mice did
take up 2 times more [3H]-CEt from HDL by liver as compared
to WT mice. This clearly indicates that endogenous HDL could
competewith [3H]-CEt-HDL for uptakeby the liver, thereby inhibit-
ing the clearance of [3H]-CEt-HDL in wildtype mice. Importantly,
the absence of the endogenous HDL pool in ABCA1 KO and dKO
mice allowed us to study the role of SR-BI in HDL catabolism in
absence of competition with endogenous HDL in the circulation.
We hereby thus for the ﬁrst time provide direct compelling in vivo
evidence that SR-BI is the determining factor for the selective
uptake CE from HDL by liver in the absence of the endogenous HDL
pool.
Interestingly, dKO mice also resembled the single ABCA1 KOs
in non-HDL-C levels, which were signiﬁcantly lower than WT
and SR-BI KO mice. VLDL production, however, was increased in
dKO and single ABCA1 KO mice. Chung et al. previously demon-
strated that pre- migrating nascent HDL generated by ABCA1
inhibits VLDL production through activation of phosphoinositide
3 (PI3)-kinase [30]. As a result, ABCA1 deﬁciency leads to increased
VLDL production in vivo secondary to reduced PI3-kinase signaling
[31]. Moreover, SR-BI has been shown to promote VLDL produc-
tion through induction of microsomal triglyceride transfer protein
(MTP) activity [32], which might also be regulated via PI3-kinase
signaling [33]. In the present study and previous studies [22], we
could not show the effect of SR-BI deﬁciency on VLDL production.
SR-BI KO mice, however, do display increased non-HDL choles-
terol levels which can be attributed to a direct role of SR-BI in
the clearance of VLDL [22]. In the absence of competition with
endogenous HDL, VLDL clearance via SR-BI thus might also con-
tribute to the lower levels of non-HDL-C in ABCA1 KO mice. In
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Fig. 6. Enhanced macrophage foam cell formation but no atherosclerosis in ABCA1/SR-BI double knockout mice. (A and B) A necropsy was performed on mice at the age of 16
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ontrast, the decreased non-HDL-C levels in the circulation of dKO
ice are probably the consequence of compensatory upregulation
f LRP1-mediated clearance pathway in the liver.
In agreement with a previous study showing that biliary choles-
erol secretion is not affected by the absence of HDL [27], our single
BCA1 KO and dKO mice did not display impaired biliary choles-
erol secretion. The reduced biliary cholesterol secretion in SR-BI
Omicewas observed in previous studies [34–36],which could not
e conﬁrmed in the current study. Differences in the background
f mice [34,35] and treatment of mice, e.g. dietary challenge [35]
nd viral exposure [36], between the present study and previous
tudies might account for this different observation. The low lev-
ls of basal biliary cholesterol secretion in our single SR-BI KO and
KO mice indicate that SR-BI might not be essential for the basal
holesterol secretion or that the other cholesterol secretion path-
ays suchasABCG5andABCG8are redundantunder this condition.
lthough overexpression of SR-BI could increase biliary secretion
n the absence of ABCG5 and ABCG8 [37], our results indicate that
he contribution of SR-BI at the physiological level to the biliary
holesterol secretion still needs further investigation.
Despite being a tiny pool for RCT, macrophage RCT is crucial for
he prevention of macrophage foam cell formation and atheroscle-
osis [38]. Inactivation of ABCA1 results in HDL deﬁciency, thereby
mpairing macrophage RCT [10,11]. Blocking the hepatic CE uptake
rom HDL by the deletion of SR-BI also impairs macrophage RCT
17]. In line, HDL deﬁciency in ABCA1/SR-BI dKO mice did lead
o the reduced transport of the [3H]-cholesterol tracer from WT
acrophages to feces. SR-BI deﬁciency, however, did not furthermpair macrophage RCT in the dKO mice as compared to single
BCA1 KO mice. Thus, in dKO mice, the effect of ABCA1 on genera-
ion ofHDL rather than the delivery ofHDL-C to the liver via SR-BI is
he rate limiting factor for macrophage RCT. Notably, in ABCA1/SR-d-O and a rat monoclonal antibody against Moma-2 to visualize lipid accumulation
at the aortic root of mice at the age of 1 year old on chow diet. Representative
BI dKO mice, a substantial amount of the [3H]-cholesterol tracer
could still be transferred from WT macrophages to the feces. [3H]-
cholesterol from the macrophages is detected in plasma not only
in the HDL pool but also in the non-HDL pool [10,11]. There-
fore, non-HDL lipoproteins might also participate in macrophage
RCT. Augmentation of the clearance of non-HDL lipoproteins by
liver might be thus important for promoting macrophage RCT,
thereby protecting against foam cell formation and atherosclero-
sis. In line, macrophage-derived apoE promotes both the clearance
of non-HDL lipoproteins [39] and macrophage-speciﬁc reverse
cholesterol transport in apoE KO mice [40]. Moreover, erythro-
cytes and albumin might also aid the transport of cholesterol
through the circulation [41,42]. In addition, Van der Velde et al.
reported a novel reverse cholesterol transport pathway, namely
transintestinal cholesterol transport (TICE) that directly transfers
cholesterol fromblood to the intestinal lumen via enterocytes. TICE
can contribute for up to 70% of the daily total body neutral sterol
secretion in mice [43]. Interestingly, TICE is not mediated through
HDL particles because ABCA1 KO and our dKO mice show unal-
tered TICE (C.L.J. Vrins, unpublished data). How important TICE is
for macrophage RCT, however, remains to be determined.
ABCA1/SR-BI dKO mice display enhanced macrophage foam
cell formation in the lung and Peyer’s patches. Macrophages
cannot limit the uptake of cholesterol and thus depend on choles-
terol efﬂux mechanisms to prevent foam cell formation. ABCA1,
ABCG1, and SR-BI are important players in cholesterol efﬂux from
macrophages [44]. ABCA1 and ABCG1 actively transfer cholesterol
to lipid-free/poor apoAI and mature HDL, respectively while SR-BI
induces cholesterol efﬂux to a phospholipid-containing acceptor
likematureHDLdownaconcentrationgradient.HDLdeﬁciencyand
reduced macrophage RCT in single ABCA1 KO and dKO mice thus
contribute to the macrophage foam cell formation observed in the
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ung and the Peyer’s patches. Interestingly, However, since more
xtreme foam cell formation was observed in dKO mice as com-
ared to ABCA1KOmice, probably also absence of ABCA1 and SR-BI
n themacrophageswill have contribution to theobserved foamcell
ormation.Wang et al. recently demonstrated thatmacrophage SR-
I does not promotemacrophage RCT [45]. In the present study, we
lso failed to pick up the effect ofmacrophage SR-BI onmacrophage
CT. However, cholesterol loading in vitro does downregulate the
xpression of SR-BI on WT macrophages [46]. Importantly, in pre-
ious bone marrow transplantation studies, we have shown that
ombined deﬁciency of macrophage ABCA1 and SR-BI did lead to
assive foam cell formation in the peritoneal cavity and spleen of
DLr KO mice transplanted with dKO bone marrow and challenged
ith a Western-type diet [47]. Thus, the combined role of ABCA1
nd SR-BI in cholesterol efﬂux could account for the enhanced for-
ation of macrophage foam cells in the lung and Peyer’s patches
f the dKO mice in vivo. Interestingly, ABCA1/ABCG1 dKO mice
howed even more extreme foam cell formation in the peritoneal
avity as well as other macrophage-rich tissues, including liver,
pleen, lung, Peyer’s patches and thymus [48]. Thus, despite the
imilarity in acceptor speciﬁcity of SR-BI and ABCG1, their relative
n vivo importance could be affected by the biological environ-
ent of the macrophage and possibly the availability of substrates
47]. Interestingly, both ABCA1/ABCG1 dKO mice and ABCA1/SR-BI
KO mice show enhanced foam cell formation under hypocholes-
erolemia. The source of lipids for the observed foam cell formation
s still elusive. Recent ﬁndings indicate that Toll-like receptor acti-
ation induces macrophage foam cell formation by promoting the
ipid droplet formation in the absence of extracellular lipids [49].
hether this mechanism contributes to the foam cell formation
n our dKO mice warrants further investigation in future. Of note,
ike ABCA1/ABCG1 dKO mice [48], ABCA1/SR-BI dKO mice did not
evelop atherosclerotic lesions, further indicating the importance
f high levels of atherogenic lipoproteins for the development of
therosclerosis.
In summary, by characterizing our unique ABCA1/SR-BI dKO
ice, we have provided more insight into the important roles of
BCA1 and SR-BI in lipid metabolism and macrophage foam cell
ormation invivo.Ourdata indicate that bothABCA1-mediatedHDL
eneration and HDL-CE delivery to the liver via SR-BI are essential
or macrophage RCT. Macrophage foam cells can be formed under
ypocholesterolemia, while the presence of high levels of athero-
enic lipoproteins is essential for the induction of atherosclerotic
esion formation.
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